1. Sontag SJ: The medical management of reflux esophagitis. Role of antacids and acid inhibition. Gastroenterol Clin of North Am 19(3):683–712, 1990
2. Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy HJ, Mitchell B, Beveridge BR, Laurence BH, Gibson GG, Grant AK, Shearman DJC, Whitehead R, Buckle PJ: Healing and relapse of severe peptic oesophagitis after treatment with omeprazole. Gastroenterology 95:903–912, 1988
3. Sontag SJ, Hirschowitz BI, Holt S, Robinson MG, Behar J, Berenson MM, McCullough A, Ippoliti AF, Richter JE, Ahtaridis G, McCallum RW, Pambianco DH, Vlahcevic RZ, Johnson DA, Collen MJ, Lyon DT, Humphries TH, Cagliola A, Berman RS: Two doses of omeprazole versus placebo in symptomatic erosive esophagitis. The U.S. Multicenter Study. Gastroenterology 102:109–118, 1992
4. Sugiyama M, Ishikawa T, Aoki T, Kashiwagi H, Watanabe Y, Sasaki H, Yoshino K: Effect of lansoprazole (AG-1749) on gastric acidd secretion—inhibition of insulin-stimulated acid secretion. Shokakika 14(2):183–193, 1991
5. Hogan DL, Koss MA, Feitelberg S, Hussein Z, Karol MD, Isenberg JI: Single and repetitive administration of lansoprazole: Effects on gastric acid secretion, pharmacokinetics and serum gastrin in old vs young subjects. Gastroenterology 100:A84, 1991 (abstract)